{"id":46031,"date":"2026-02-19T03:33:41","date_gmt":"2026-02-19T03:33:41","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/sickle-cell-treatment-market-mordor\/"},"modified":"2026-09-25T00:35:55","modified_gmt":"2026-09-24T15:35:55","slug":"sickle-cell-treatment-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/sickle-cell-treatment-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uacb8\uc0c1 \uc801\ud608\uad6c \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026 &#8211; 2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/sickle-cell-treatment-market-1752244642181-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/sickle-cell-treatment-market-size-image-1771002703455.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uacb8\uc0c1 \uc801\ud608\uad6c \ub3cc\uc5f0\ubcc0\uc774 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uacac\uace0\ud55c \ud6c4\uae30 \ub2e8\uacc4 R&amp;D \ud30c\uc774\ud504\ub77c\uc778<\/li>\n<li class=\"toc-level-3\">4.2.3 \uaddc\uc81c \uc2e0\uc18d \uc2ec\uc0ac \ubc0f \ud76c\uadc0 \uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc9c8\ubcd1 \uc870\uc808 \uc57d\ubb3c(\ubcf5\uc140\ub85c\ud130, \ud06c\ub9ac\uc794\ub9ac\uc8fc\ub9d9)\uc758 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74\uc758 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.6 \uce58\ub8cc \uc720\uc804\uc790 \ud3b8\uc9d1 \uc694\ubc95\uc5d0 \ub300\ud55c \uac00\uce58 \uae30\ubc18 \uc0c1\ud658<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \ucd1d \uce58\ub8cc \ube44\uc6a9 \ubc0f \uc77c\ud68c\uc131 \uc720\uc804\uc790 \ud3b8\uc9d1 \uac00\uaca9<\/li>\n<li class=\"toc-level-3\">4.3.2 HSCT\ub97c \uc704\ud55c \uc77c\uce58\ud558\ub294 \uae30\uc99d\uc790 \uac00\uc6a9\uc131 \uc81c\ud55c<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMICs)\uc758 \ucf5c\ub4dc \uccb4\uc778 \ubc0f \uc8fc\uc785 \uc13c\ud130 \uc778\ud504\ub77c \uaca9\ucc28<\/li>\n<li class=\"toc-level-3\">4.3.4 \ubd88\uade0\ub4f1\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ubc94\uc704 \ubc0f \ud61c\ud0dd \uc124\uacc4 \uc81c\uc678<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc591\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc218\ud608<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd (HSCT)<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc57d\ubb3c \uce58\ub8cc<\/li>\n<li class=\"toc-level-4\">5.1.3.1 \ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544<\/li>\n<li class=\"toc-level-4\">5.1.3.2 L-\uae00\ub8e8\ud0c0\ubbfc<\/li>\n<li class=\"toc-level-4\">5.1.3.3 \ubcf5\uc140\ub85c\ud130<\/li>\n<li class=\"toc-level-4\">5.1.3.4 \ud06c\ub9ac\uc794\ub9ac\uc8fc\ub9d9<\/li>\n<li class=\"toc-level-4\">5.1.3.5 \uae30\ud0c0 (\ud1b5\uc99d \uad00\ub9ac, \uc5fd\uc0b0 \ud3ec\ud568)<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc720\uc804\uc790 \ud3b8\uc9d1 \/ \uc720\uc804\uc790 \ucd94\uac00 \uce58\ub8cc\ubc95<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ud658\uc790 \uc5f0\ub839 \uadf8\ub8f9\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc18c\uc544 (0\u201317\uc138)<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc131\uc778 (18\u201349\uc138)<\/li>\n<li class=\"toc-level-3\">5.2.3 \uace0\ub839 \uc131\uc778 (50\uc138 \uc774\uc0c1)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c8\ubcd1 \uc911\uc99d\ub3c4 \/ \uc784\uc0c1 \ubaa9\ud45c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uae09\uc131 \uc704\uae30 \uad00\ub9ac<\/li>\n<li class=\"toc-level-3\">5.3.2 \ub9cc\uc131 \uc9c8\ud658 \uc644\ud654<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc644\uce58 \/ \uc7a0\uc7ac\uc801 \uc644\uce58<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc678\ub798 \uc218\uc220 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.4.4 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 \ub178\ubc14\ud2f0\uc2a4 AG<\/li>\n<li class=\"toc-level-3\">6.3.2 \ud654\uc774\uc790 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.3 \uc0ac\ub178\ud53c SA<\/li>\n<li class=\"toc-level-3\">6.3.4 \ubc84\ud14d\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 \ud06c\ub9ac\uc2a4\ud37c \ud14c\ub77c\ud4e8\ud2f1\uc2a4 AG<\/li>\n<li class=\"toc-level-3\">6.3.6 \uc5e0\ub9c8\uc6b0\uc2a4 \ub77c\uc774\ud504 \uc0ac\uc774\uc5b8\uc2a4 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 \ud14c\ubc14 \uc81c\uc57d \uc0b0\uc5c5 Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.8 \ud788\ud06c\ub9c8 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4 PLC<\/li>\n<li class=\"toc-level-3\">6.3.9 \uc2dc\ud50c\ub77c Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.10 \uc544\ud3ec\ud14d\uc2a4 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.11 \uc0b0\ub3c4\uc2a4 \uadf8\ub8f9 AG<\/li>\n<li class=\"toc-level-3\">6.3.12 \ud504\ub808\uc81c\ub2c8\uc6b0\uc2a4 \uce74\ube44 AG<\/li>\n<li class=\"toc-level-3\">6.3.13 \ud14c\ub8e8\ubaa8 BCT Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 \uc138\ub7ec\uc2a4 \ucf54\ud37c\ub808\uc774\uc158<\/li>\n<li class=\"toc-level-3\">6.3.15 \uadf8\ub9ac\ud3f4\uc2a4 SA<\/li>\n<li class=\"toc-level-3\">6.3.16 CSL \ubca0\ub9c1 GmbH<\/li>\n<li class=\"toc-level-3\">6.3.17 \ucf00\ub4dc\ub9ac\uc628 \ubc14\uc774\uc624\ud30c\ub9c8 SpA<\/li>\n<li class=\"toc-level-3\">6.3.18 \ubc15\uc2a4\ud130 \uc778\ud130\ub0b4\uc154\ub110 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 \uba54\ub4dc\uc720\ub2c8\ud06c USA<\/li>\n<li class=\"toc-level-3\">6.3.20 \uc5b4\ucf54\ub4dc \ud5ec\uc2a4\ucf00\uc5b4 Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>\uae00\ub85c\ubc8c \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc740 2025\ub144 36.9\uc5b5 \ub2ec\ub7ec\ub85c \ud3c9\uac00\ub418\uc5c8\uc73c\uba70, 2026\ub144 42.3\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uc5d0\ub294 84.1\uc5b5 \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud558\uc5ec \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 14.72%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uac00\uc18d\ud654\ub41c \uc131\uc7a5\uc740 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc \uc2b9\uc778, \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud655\ub300, \uadf8\ub9ac\uace0 \uc9c4\ud654\ud558\ub294 \uac00\uce58 \uae30\ubc18 \uc9c0\ubd88 \ubaa8\ub378\uacfc \uac19\uc740 \uc8fc\uc694 \ub3d9\uc778\ub4e4\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc57d\ubb3c \uce58\ub8cc\ub294 \uc5ec\uc804\ud788 \uac00\uc7a5 \ud070 \ub9e4\ucd9c \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc644\uce58 \ubaa9\uc801\uc758 \uc720\uc804\uc790 \uce58\ub8cc\ub294 \uace0\uac00\uc758 \ud504\ub9ac\ubbf8\uc5c4 \uc2dc\uc7a5\uc744 \ud615\uc131\ud558\uba70 \uc7a5\uae30\uc801\uc778 \uc9c8\ubcd1 \uad00\ub9ac\ub97c \uc7ac\uc815\uc758\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc758 \uc0c1\ud658 \ubaa8\ub378 \uc2e4\ud5d8, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uc778\ud504\ub77c \uad6c\ucd95, \uadf8\ub9ac\uace0 \uc8fc\uc694 \uae30\uad00\ub4e4\uc758 \ud76c\uadc0 \uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c\ub294 \uc804\ubc18\uc801\uc778 \uc218\uc694\ub97c \uac15\ud654\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc800\uc18c\ub4dd \uc9c0\uc5ed\uc5d0\uc11c\ub294 \uacf5\uae09\ub9dd \uaca9\ucc28, \uc81c\ud55c\uc801\uc778 \ubcf4\ud5d8 \uc801\uc6a9, \uc778\ub825 \ubd80\uc871 \ub4f1\uc73c\ub85c \uc778\ud574 \ucca8\ub2e8 \uce58\ub8cc\ubc95\uc758 \ub3c4\uc785\uc774 \uc9c0\uc5f0\ub418\ub294 \uc5b4\ub824\uc6c0\uc774 \uc9c0\uc18d\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc694\uc57d:<br \/>\n*   \uce58\ub8cc \ubc29\uc2dd: 2025\ub144 \uc57d\ubb3c \uce58\ub8cc\uac00 45.97%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc73c\uba70, \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\ub294 2031\ub144\uae4c\uc9c0 17.05%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ud658\uc790 \uc5f0\ub839\ub300: 2025\ub144 \uc18c\uc544 \ud658\uc790\uad70\uc774 50.12%\ub85c \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc131\uc778 \ud658\uc790\uad70\uc740 2031\ub144\uae4c\uc9c0 15.76%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc911\uc99d\ub3c4: 2025\ub144 \ub9cc\uc131 \uc9c8\ubcd1 \uc870\uc808 \uce58\ub8cc\uac00 57.74%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uae30\ub85d\ud588\uc73c\uba70, \uc644\uce58 \uc811\uadfc\ubc95\uc740 \uac19\uc740 \uae30\uac04 \ub3d9\uc548 18.12%\uc758 CAGR\ub85c \ubc1c\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790: 2025\ub144 \ubcd1\uc6d0\uc774 59.05%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\ub85c \uc9c0\ubc30\uc801\uc774\uc5c8\uc73c\ub098, \uc678\ub798 \uc218\uc220 \uc13c\ud130\ub294 2031\ub144\uae4c\uc9c0 15.44%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed: 2025\ub144 \ubd81\ubbf8\uac00 35.92%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc9c0\ub9cc, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 15.93%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825:<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778:<br \/>\n*   \uacb8\uc0c1 \uc801\ud608\uad6c \ubcc0\uc774 \uc720\ubcd1\ub960 \uc99d\uac00: 2021\ub144 \uc804 \uc138\uacc4\uc801\uc73c\ub85c 515,000\uba85\uc758 \ucd9c\uc0dd\uc544\uac00 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d\uc758 \uc601\ud5a5\uc744 \ubc1b\uc558\uc73c\uba70, \uc5f0\uac04 376,000\uba85\uc758 \uc0ac\ub9dd\uc790\uac00 \ubc1c\uc0dd\ud558\uc5ec \ub2e4\uc9c0\uc5ed\uc801 \uce58\ub8cc \uc218\uc694\ub97c \uc9c0\uc18d\uc801\uc73c\ub85c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub098\uc774\uc9c0\ub9ac\uc544\uac00 \uc804 \uc138\uacc4 \ud658\uc790 \ud480\uc758 3\ubd84\uc758 1\uc744 \ucc28\uc9c0\ud558\uba70, \uc774\ubbfc\uc73c\ub85c \uc778\ud574 \uc720\ub7fd\uacfc \uac78\ud504 \uc9c0\uc5ed\uc5d0\uc11c\ub3c4 \ud658\uc790 \uc218\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uace0\uc18c\ub4dd \uad6d\uac00\uc758 \uc218\uba85 \uc5f0\uc7a5\uc740 \uc7a5\uae30\uc801\uc778 \uc9c8\ubcd1 \uc870\uc808 \ub610\ub294 \uc644\uce58 \uc635\uc158\uc744 \ud544\uc694\ub85c \ud558\ub294 \uc131\uc778 \ud658\uc790\uc758 \uc99d\uac00\ub97c \uc57c\uae30\ud569\ub2c8\ub2e4.<br \/>\n*   \uacac\uace0\ud55c \ud6c4\uae30 \uc784\uc0c1 \uac1c\ubc1c \ud30c\uc774\ud504\ub77c\uc778: \uc720\uc804\uc790 \ud3b8\uc9d1, \ub300\uc0ac \uc870\uc808\uc81c, \ud6c4\uc131 \uc720\uc804 \uc870\uc808\uc81c \ub4f1\uc774 2\uc0c1 \ubc0f 3\uc0c1 \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8\uc744 \ud1b5\ud574 \uac15\ub825\ud55c \uc784\uc0c1 \ubaa8\uba58\ud140\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Etavopivat, mitapivat, Novartis dWIZ-1, Fulcrum\uc758 \ud6c4\ubcf4 \ubb3c\uc9c8 \ub4f1\uc774 \uc0c8\ub85c\uc6b4 \uc791\uc6a9 \uba54\ucee4\ub2c8\uc998\uc744 \uc81c\uc2dc\ud558\uba70 \ud30c\uc774\ud504\ub77c\uc778\uc744 \ud655\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uaddc\uc81c \uc2e0\uc18d \uc2b9\uc778 \ubc0f \ud76c\uadc0 \uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c: \ubbf8\uad6d FDA\ub294 Casgevy\uc640 Lyfgenia\ub97c \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815 \ubc0f \uc6b0\uc120 \uc2ec\uc0ac\ub97c \ud1b5\ud574 \uc804\ub840 \uc5c6\ub294 \uc18d\ub3c4\ub85c \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4. \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA)\uacfc\uc758 \uc870\uc728\uc740 \uc720\ub7fd \ub0b4 \uc811\uadfc\uc131\uc744 \ub2e8\ucd95\ud558\uace0 \uc9c0\ubd88\uc790\uc5d0\uac8c \ud1b5\uc77c\ub41c \ucc38\uc870 \uac00\uaca9\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc870\uc808 \uc57d\ubb3c\uc758 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc: Voxelotor, crizanlizumab, L-glutamine\uc740 \ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544 \ub2e8\ub3c5 \uc694\ubc95\uc744 \ub118\uc5b4\uc120 \uce58\ub8cc \uc635\uc158\uc744 \uc81c\uacf5\ud558\uba70 \ud608\uad00 \ud3d0\uc1c4\uc131 \uc704\uae30(VOC)\ub97c \ub354 \uc798 \uc870\uc808\ud558\ub294 \ubcf5\ud569 \uc694\ubc95\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uac15\uc870\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74\uc758 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud655\ub300: \uc9c4\ub2e8\ub41c \ud658\uc790 \ud480\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc644\uce58 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\uc5d0 \ub300\ud55c \uac00\uce58 \uae30\ubc18 \uc0c1\ud658: \ubd81\ubbf8 \uc9c0\uc5ed\uc5d0\uc11c \uc8fc\ub3c4\uc801\uc73c\ub85c \ub3c4\uc785\ub418\uace0 \uc788\uc73c\uba70, \uc720\ub7fd\uc5d0\uc11c\ub3c4 \ucd08\uae30 \ucc44\ud0dd\uc774 \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \uc800\ud574 \uc694\uc778:<br \/>\n*   \ub192\uc740 \ucd1d \uce58\ub8cc \ube44\uc6a9 \ubc0f \uc77c\ud68c\uc131 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc \uac00\uaca9: Casgevy(220\ub9cc \ub2ec\ub7ec) \ubc0f Lyfgenia(310\ub9cc \ub2ec\ub7ec)\uc758 \uc0c1\uc5c5\uc801 \uc815\uac00\ub294 \ubcd1\uc6d0 \uc785\uc6d0 \uac10\uc18c\ub85c \uc778\ud55c \ud3c9\uc0dd \uc808\uac10 \ud6a8\uacfc\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc7ac\uc815\uc801 \ubd80\ub2f4\uc744 \uc57c\uae30\ud569\ub2c8\ub2e4.<br \/>\n*   \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd(HSCT)\uc744 \uc704\ud55c \uc77c\uce58\ud558\ub294 \uacf5\uc5ec\uc790 \ubd80\uc871: \uc804 \uc138\uacc4\uc801\uc73c\ub85c, \ud2b9\ud788 \uc720\uc804\uc801 \ub2e4\uc591\uc131\uc774 \ub192\uc740 \uc9c0\uc5ed\uc5d0\uc11c \ub354 \uc2ec\uac01\ud55c \ubb38\uc81c\ub85c \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMICs)\uc758 \ucf5c\ub4dc \uccb4\uc778 \ubc0f \uc8fc\uc785 \uc13c\ud130 \uc778\ud504\ub77c \ubd80\uc871: \ub9ce\uc740 \uc544\ud504\ub9ac\uce74 \uace0\ubd80\ub2f4 \uad6d\uac00\ub4e4\uc740 \uc0dd\uccb4 \uc678 \uc720\uc804\uc790 \uce58\ub8cc\uc5d0 \ud544\uc694\ud55c \uc548\uc815\uc801\uc778 \uc804\uae30, \ucca8\ub2e8 \uc2e4\ud5d8\uc2e4, \ud6c8\ub828\ub41c \uc8fc\uc785 \ud300\uc774 \ubd80\uc871\ud569\ub2c8\ub2e4.<br \/>\n*   \ubd88\uade0\ub4f1\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ubc0f \ud61c\ud0dd \uc124\uacc4 \uc81c\uc678: \uc9c0\ubd88 \ubaa8\ub378\uc5d0 \ub530\ub77c \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ubcf4\ud5d8 \uc801\uc6a9 \ubc94\uc704\uc5d0 \ud070 \ucc28\uc774\uac00 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d:<br \/>\n*   \uce58\ub8cc \ubc29\uc2dd: \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\ub294 2026\ub144\uc5d0\uc11c 2031\ub144 \uc0ac\uc774\uc5d0 17.05%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud558\uba70, \uc77c\ud68c\uc131 \uc644\uce58 \uac1c\uc785\uc5d0 \ub300\ud55c \uc9c0\ubd88\uc790\uc758 \ub192\uc740 \uad00\uc2ec\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc57d\ubb3c \uce58\ub8cc\ub294 2025\ub144 45.97%\uc758 \ub9e4\ucd9c \ube44\uc911\uc744 \uc720\uc9c0\ud558\uba70 \ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544 \ubc0f \ucd5c\uadfc \ub3c4\uc785\ub41c \uc9c8\ubcd1 \uc870\uc808 \uc57d\ubb3c\uc5d0 \ub300\ud55c \uafb8\uc900\ud55c \uc218\uc694\ub97c \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd\uc740 \uacf5\uc5ec\uc790 \uc81c\ud55c\uacfc \ucee8\ub514\uc154\ub2dd \uad00\ub828 \uc774\ud658\uc728\ub85c \uc778\ud574 \uc2dc\uc220\ub7c9\uc5d0 \uc81c\uc57d\uc744 \ubc1b\uc2b5\ub2c8\ub2e4. Bluebird Bio\uc640 Vertex\ub294 \uc0c1\uc774\ud55c \ucd9c\uc2dc \uc804\ub7b5\uc744 \ucc44\ud0dd\ud558\uace0 \uc788\uc73c\uba70, Tessera Therapeutics\ub294 \ucc44\ucde8 \ubc0f \uc7ac\uc8fc\uc785 \ub2e8\uacc4\ub97c \uc6b0\ud68c\ud560 \uc218 \uc788\ub294 \uc0dd\uccb4 \ub0b4 \uc720\uc804\uc790 \ud3b8\uc9d1 \uae30\uc220\uc744 \ud0d0\uc0c9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud658\uc790 \uc5f0\ub839\ub300: 18-49\uc138 \uc131\uc778 \ud658\uc790\uad70\uc740 \uc0dd\uc874\uc728 \ud5a5\uc0c1\uacfc \uc720\uc804\uc790 \uce58\ub8cc \uc801\uaca9\uc131 \uae30\uc900 \ud3ec\ud568\uc5d0 \ud798\uc785\uc5b4 15.76%\uc758 CAGR\uc744 \uae30\ub85d\ud588\uc2b5\ub2c8\ub2e4. \uc18c\uc544 \ud658\uc790\uad70\uc740 \uc758\ubb34 \uc120\ubcc4 \uac80\uc0ac \ubc0f \uc870\uae30 \uac1c\uc785 \ud504\ub85c\uadf8\ub7a8\uc5d0 \ud798\uc785\uc5b4 2025\ub144 50.12%\uc758 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uace0\ub839 \ud658\uc790\uad70\uc740 \ub204\uc801\ub41c \uc7a5\uae30 \ud569\ubcd1\uc99d\uc73c\ub85c \uc778\ud574 \ubcf5\ud569 \uce58\ub8cc \ubc0f \ub2e4\ud559\uc81c\uc801 \ucd94\uc801 \uad00\ucc30\uc774 \ud544\uc694\ud569\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc911\uc99d\ub3c4: \uc644\uce58 \ubc0f \uc7a0\uc7ac\uc801 \uc644\uce58 \uc635\uc158\uc740 18.12%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uba70 \uc2ec\uac01\ud558\uace0 \uc7ac\ubc1c\uc131 \uc704\uae30\ub97c \uacaa\ub294 \ucd08\uae30 \ud658\uc790\ub4e4\uc5d0\uac8c \ucc44\ud0dd\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \ub9cc\uc131 \uc9c8\ubcd1 \uc870\uc808 \uce58\ub8cc\ub294 2025\ub144 \ub9e4\ucd9c\uc758 57.74%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544, crizanlizumab, L-glutamine\uc774 \uc8fc\ub3c4\ud588\uc2b5\ub2c8\ub2e4. Lyfgenia\ub294 \uce58\ub8cc \ud658\uc790\uc758 94%\uc5d0\uc11c \uc2ec\uac01\ud55c \ud608\uad00 \ud3d0\uc1c4\uc131 \uc0ac\uac74\uc744 \ud574\uacb0\ud588\uc73c\uba70, Casgevy\ub294 1\ub144 \ub3d9\uc548 97%\uc5d0\uc11c \uc2ec\uac01\ud55c \uc704\uae30 \uc5c6\ub294 \uc0c1\ud0dc\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790: \ubcd1\uc6d0\uc740 \uc751\uae09 \uad00\ub9ac \ubc0f \ucee8\ub514\uc154\ub2dd \uc694\ubc95\uc5d0\uc11c\uc758 \uc5ed\ud560\ub85c \uc778\ud574 2025\ub144 \ub9e4\ucd9c\uc758 59.05%\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc678\ub798 \uc218\uc220 \uc13c\ud130\ub294 \uc678\ub798 \uc720\uc804\uc790 \uce58\ub8cc \ud504\ub85c\ud1a0\ucf5c\uc758 \uaddc\uc81c \uc2b9\uc778\uc73c\ub85c 15.44%\uc758 CAGR\ub85c \uc131\uc7a5\ud588\uc2b5\ub2c8\ub2e4. Bluebird\uc758 70\uac1c \uc0ac\uc774\ud2b8\uc640 Vertex\uc758 35\uac1c \ud5c8\ube0c \ubaa8\ub378\uc740 \uc804\ubb38\ud654\ub41c \uace0\ucc98\ub9ac\ub7c9 \uc6b0\uc218 \uc13c\ud130\ub85c\uc758 \uc804\ud658\uc744 \uac15\uc870\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d:<br \/>\n*   \ubd81\ubbf8: 2025\ub144 35.92%\uc758 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc870\uae30 \uc2b9\uc778, \ub192\uc740 \ubcf4\ud5d8 \uc801\uc6a9\ub960, \ubc00\uc9d1\ub41c \uc804\ubb38\uc758 \ub124\ud2b8\uc6cc\ud06c \ub355\ubd84\uc785\ub2c8\ub2e4. \ubbf8\uad6d\uc740 CMS\ub97c \ud1b5\ud55c \uac00\uce58 \uae30\ubc18 \uc9c0\ubd88 \ubaa8\ub378 \uc124\uacc4\ub97c \ud1b5\ud574 \uae00\ub85c\ubc8c \uc0c1\ud658 \ub17c\uc758\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 15.93%\uc758 CAGR\ub85c \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5 \ubaa8\uba58\ud140\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc778\ub3c4\uc758 \uad6d\uac00 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \ud1f4\uce58 \ubbf8\uc158\uc740 17\uac1c \uc8fc \uc804\uc5ed\uc5d0 \ubcf4\ud3b8\uc801 \uc120\ubcc4 \uac80\uc0ac\ub97c \uc2dc\ud589\ud558\uace0 \ud658\uc790 \uad50\uc721 \ubc0f \uc57d\ubb3c \uce58\ub8cc \ubcf4\uc870\uae08\uc744 \ud1b5\ud569\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub9d0\ub808\uc774\uc2dc\uc544, \ud0dc\uad6d, \uc778\ub3c4\ub124\uc2dc\uc544\uc5d0\uc11c\ub294 \uacf5\uae09\uc790\uc758 78%\uac00 \uce58\ub8cc \uacbd\uc81c\uc131\uc744 \uc8fc\uc694 \uc7a5\ubcbd\uc73c\ub85c \uaf3d\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \uac15\ub825\ud55c \uc0ac\ud68c \ubcf4\ud5d8 \uc2dc\uc2a4\ud15c\uacfc EMA \uaddc\uc81c \uc870\uc728\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud55c \ucc44\ud0dd\uc744 \ubcf4\uc785\ub2c8\ub2e4. \ub3c5\uc77c\uacfc \ud504\ub791\uc2a4\ub294 \uc704\ud5d8 \ubd84\ub2f4 \uacc4\uc57d \ud558\uc5d0 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\ub97c \uc0c1\ud658\ud558\uba70, \uc601\uad6d\uc740 \uc608\uc0b0 \uc8fc\uae30\uc5d0 \uac78\uccd0 \ube44\uc6a9\uc744 \ubd84\uc0b0\ud558\ub294 \uc5f0\uae08 \uc9c0\ubd88 \uad6c\uc870\ub97c \uc2dc\ubc94 \uc6b4\uc601\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74: \uc2dc\uc7a5\uc774 \uc591\ubd84\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\ub808\uc778\uacfc \uac19\uc740 \uac78\ud504 \uad6d\uac00\ub4e4\uc740 \uc815\ubc00 \uc758\ud559\uc5d0 \uc9d1\uc911 \ud22c\uc790\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74\ub294 \ub192\uc740 \uc720\ubcd1\ub960\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc778\ud504\ub77c \ud55c\uacc4\ub85c \ucca8\ub2e8 \uc81c\ud488 \ucc44\ud0dd\uc774 \uc9c0\uc5f0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4. Vertex Pharmaceuticals\uc640 CRISPR Therapeutics\ub294 Casgevy\ub97c \ud1b5\ud574 \uc720\uc804\uc790 \ud3b8\uc9d1 \ubd84\uc57c\uc5d0\uc11c \uc120\uc810 \ud6a8\uacfc\ub97c \ub204\ub9ac\uba70 \ud504\ub9ac\ubbf8\uc5c4 \ud3ec\uc9c0\uc154\ub2dd\uacfc \ube0c\ub79c\ub4dc \uc778\uc9c0\ub3c4\ub97c \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. Bluebird Bio\ub294 \uc720\uc77c\ud55c \ub300\uccb4 \uc790\uac00 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub97c \uc81c\uacf5\ud558\uc9c0\ub9cc \uc790\uae08 \uc870\ub2ec \ubcf5\uc7a1\uc131\uc73c\ub85c \uc778\ud574 \ub4f1\ub85d\uc5d0 \uc5b4\ub824\uc6c0\uc744 \uacaa\uace0 \uc788\uc2b5\ub2c8\ub2e4. Novartis\ub294 \ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544 \uc81c\ub124\ub9ad, crizanlizumab \ubc0f \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud45c\uc801 \uce58\ub8cc\uc81c\ub97c \ud1b5\ud574 \uae30\uc874 \ubc0f \ucc28\uc138\ub300 \ubd80\ubb38 \ubaa8\ub450\ub97c \uc544\uc6b0\ub974\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud654\uc774\uc790\uc758 Voxelotor \uc790\ubc1c\uc801 \ud68c\uc218\ub294 \uc2dc\ud310 \ud6c4 \uc548\uc804\uc131 \uac10\uc2dc\uc758 \ubcc0\ub3d9\uc131\uc744 \uac15\uc870\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2e0\ud765 \uae30\uc220 \ucc28\ubcc4\ud654 \uc694\uc18c\ub85c\ub294 \uc0dd\uccb4 \ub0b4 \uc720\uc804\uc790 \ud3b8\uc9d1, \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \uc804\ub2ec, \ud5e4\ubaa8\uae00\ub85c\ube48 \uc911\ud569\uc744 \ubaa9\ud45c\ub85c \ud558\ub294 \uacbd\uad6c \uc870\uc808\uc81c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. Gates \uc7ac\ub2e8\uc758 \uc9c0\uc6d0\uc744 \ubc1b\ub294 Tessera Therapeutics\ub294 \uc790\uc6d0 \uc9d1\uc57d\uc801\uc778 \uc0dd\uccb4 \uc678 \ud504\ub85c\ud1a0\ucf5c\uc744 \ub300\uccb4\ud560 \uc218 \uc788\ub294 \ub2e8\uc77c \uc6a9\ub7c9 \uc815\ub9e5 \ud22c\uc5ec \ubc29\uc2dd\uc744 \ucd94\uad6c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc81c\ub124\ub9ad \uc81c\uc870\uc5c5\uccb4\ub294 \ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544 \uc2dc\uc7a5\uc5d0\uc11c \ubb3c\ub7c9 \ub9ac\ub354\uc2ed\uc744 \uc720\uc9c0\ud558\uba70 \uc544\ud504\ub9ac\uce74 \ubc0f \ub0a8\uc544\uc2dc\uc544\uc758 \uacf5\uacf5 \ud504\ub85c\uadf8\ub7a8\uc5d0 \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 \uc635\uc158\uc744 \uc81c\uacf5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1\uc758 \uc7a5\uc740 \uc774\uc81c \ub2e8\uc21c\ud788 \ubd84\uc790\ub97c \ub118\uc5b4 \ud1b5\ud569 \uce58\ub8cc \ubaa8\ub378, \uc0ac\uc774\ud2b8 \uc778\uc99d, \uadf8\ub9ac\uace0 \uce58\ub8cc \ud6a8\uacfc \ubc0f \uac74\uac15 \uacbd\uc81c\uc801 \uac00\uce58\ub97c \uc785\uc99d\ud558\ub294 \uc2e4\uc81c \ub370\uc774\ud130 \ud30c\ud2b8\ub108\uc2ed\uc73c\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uae30\uc5c5:<br \/>\nNovartis AG, Sanofi SA, Pfizer, Vertex Pharmaceuticals Inc., CRISPR Therapeutics AG \ub4f1<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<br \/>\n*   2025\ub144 6\uc6d4: Vascarta Inc.\ub294 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc\uc81c VAS-201\uc758 \uc784\uc0c1 3\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c \uae0d\uc815\uc801\uc778 \uc911\uac04 \uacb0\uacfc\ub97c \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 5\uc6d4: Vertex Pharmaceuticals\uc640 CRISPR Therapeutics\ub294 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \uce58\ub8cc\ub97c \uc704\ud55c \uc720\uc804\uc790 \ud3b8\uc9d1 \uae30\uc220\uc758 \ucd94\uac00 \uac1c\ubc1c \ubc0f \uc0c1\uc6a9\ud654\ub97c \uc704\ud55c \uc0c8\ub85c\uc6b4 \ud611\ub825 \uacc4\uc57d\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc740 \ud2b9\uc815 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608\uc99d \ud658\uc790\ub97c \uc704\ud55c \uc0c8\ub85c\uc6b4 \uacbd\uad6c\uc6a9 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud574 \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815\uc744 \ubd80\uc5ec\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uacb8\uc0c1 \uc801\ud608\uad6c\ubcd1(Sickle Cell Disease) \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uacb8\uc0c1 \uc801\ud608\uad6c\ubcd1\uc740 \uc801\ud608\uad6c\uac00 \ub0ab \ubaa8\uc591\uc73c\ub85c \ubcc0\ud615\ub418\uc5b4 \uc870\uae30 \uc0ac\uba78\ud558\uace0 \ud608\ub958\ub97c \ub9c9\uc544 \ud1b5\uc99d\uc744 \uc720\ubc1c\ud558\ub294 \uc720\uc804\uc131 \uc9c8\ud658\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\uacb8\uc0c1 \uc801\ud608\uad6c\ubcd1 \uce58\ub8cc \uc2dc\uc7a5\uc740 2025\ub144 \uae30\uc900 42\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ud3c9\uac00\ub418\uc5c8\uc73c\uba70, 2031\ub144\uc5d0\ub294 84\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 \ud574\ub2f9 \uc2dc\uc7a5\uc758 \uacac\uace0\ud55c \uc131\uc7a5\uc138\ub97c \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uacb8\uc0c1 \uc801\ud608\uad6c \ub3cc\uc5f0\ubcc0\uc774 \uc720\ubcd1\ub960 \uc99d\uac00, \uac15\ub825\ud55c \ud6c4\uae30 \uc784\uc0c1 \ub2e8\uacc4 R&#038;D \ud30c\uc774\ud504\ub77c\uc778, \uaddc\uc81c \ub2f9\uad6d\uc758 \uc2e0\uc18d \uc2ec\uc0ac \ubc0f \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c \uc81c\uacf5\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \ubcf5\uc140\ub85c\ud130(Voxelotor) \ubc0f \ud06c\ub9ac\uc794\ub9ac\uc8fc\ub9d9(Crizanlizumab)\uacfc \uac19\uc740 \uc9c8\ubcd1 \uc870\uc808 \uc57d\ubb3c\uc758 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc \ud655\ub300, \uc0ac\ud558\ub77c \uc774\ub0a8 \uc544\ud504\ub9ac\uce74 \uc9c0\uc5ed\uc758 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud655\ub300, \uadf8\ub9ac\uace0 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \uac00\uce58 \uae30\ubc18 \uc0c1\ud658 \ubaa8\ub378 \ub3c4\uc785 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ub192\uc740 \ucd1d \uce58\ub8cc \ube44\uc6a9\uacfc \uc77c\ud68c\uc131 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\uc81c\uc758 \uace0\uac00 \uc815\ucc45(200\ub9cc \ub2ec\ub7ec \uc774\uc0c1)\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc811\uadfc\uc131\uc744 \uc81c\ud55c\ud558\uace0 \uc2dc\uc7a5 \uce68\ud22c \uc18d\ub3c4\ub97c \ub2a6\ucd94\uba70, \uc7ac\uc815 \uc9c0\uc6d0 \uba54\ucee4\ub2c8\uc998\uc774 \ucde8\uc57d\ud55c \uc9c0\uc5ed\uc5d0\uc11c\ub294 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc744 \ucd5c\ub300 2.9%\uae4c\uc9c0 \uac10\uc18c\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd(HSCT)\uc744 \uc704\ud55c \uc801\ud569\ud55c \uacf5\uc5ec\uc790 \ubd80\uc871, \uc800\uc18c\ub4dd \ubc0f \uc911\uac04 \uc18c\ub4dd \uad6d\uac00(LMICs)\uc5d0\uc11c\uc758 \ucf5c\ub4dc \uccb4\uc778 \ubc0f \uc8fc\uc785 \uc13c\ud130 \uc778\ud504\ub77c \ubd80\uc871, \uadf8\ub9ac\uace0 \ubd88\uade0\ub4f1\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ubc94\uc704 \ubc0f \ud61c\ud0dd \uc124\uacc4 \uc81c\uc678 \ub610\ud55c \uc911\uc694\ud55c \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uce58\ub8cc \uc591\uc0c1\ubcc4 \ubd84\uc11d:<br \/>\n\uce58\ub8cc \uc591\uc0c1\ubcc4\ub85c\ub294 \ud608\uc561 \uc218\ud608, \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd(HSCT), \uc57d\ubb3c \uce58\ub8cc(\ud558\uc774\ub4dc\ub85d\uc2dc\uc6b0\ub808\uc544, L-\uae00\ub8e8\ud0c0\ubbfc, \ubcf5\uc140\ub85c\ud130, \ud06c\ub9ac\uc794\ub9ac\uc8fc\ub9d9 \ub4f1), \uadf8\ub9ac\uace0 \uc720\uc804\uc790 \ud3b8\uc9d1\/\uc720\uc804\uc790 \ucd94\uac00 \uce58\ub8cc\ubc95\uc73c\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4. \uc774 \uc911 \uc720\uc804\uc790 \ud3b8\uc9d1 \uce58\ub8cc\ubc95\uc740 Casgevy \ubc0f Lyfgenia\uc640 \uac19\uc740 \uce58\ub8cc \uc635\uc158\uc758 \ucd08\uae30 \ub3c4\uc785\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 17.05%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uba70 \uc2dc\uc7a5 \ud655\ub300\ub97c \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \uc2dc\uc7a5 \ubd84\uc11d:<br \/>\n\uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub85c \uc2dc\uc7a5\uc774 \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc778\ub3c4 \uc815\ubd80\uc758 &#8216;\uad6d\uac00 \uacb8\uc0c1 \uc801\ud608\uad6c \ube48\ud608 \ud1f4\uce58 \ubbf8\uc158&#8217;\uacfc \uac19\uc740 \uc815\ubd80 \uc774\ub2c8\uc154\ud2f0\ube0c, \uc120\ubcc4 \uac80\uc0ac \uac1c\uc120, \uc758\ub8cc \ud22c\uc790 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 15.93%\uc758 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\ud658\uc790 \uc5f0\ub839 \ubc0f \uc9c8\ubcd1 \uc911\uc99d\ub3c4\ubcc4 \ubd84\uc11d:<br \/>\n\ud658\uc790 \uc5f0\ub839 \uadf8\ub8f9\uc740 \uc18c\uc544(0-17\uc138), \uc131\uc778(18-49\uc138), \uace0\ub839 \uc131\uc778(50\uc138 \uc774\uc0c1)\uc73c\ub85c \ub098\ub258\uba70, \uc9c8\ubcd1 \uc911\uc99d\ub3c4\/\uc784\uc0c1 \ubaa9\ud45c\uc5d0 \ub530\ub77c \uae09\uc131 \uc704\uae30 \uad00\ub9ac, \ub9cc\uc131 \uc9c8\ud658 \uc870\uc808, \uc644\uce58\/\uc7a0\uc7ac\uc801 \uc644\uce58\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uacbd\uc7c1 \ud658\uacbd:<br \/>\n\ucd5c\uc885 \uc0ac\uc6a9\uc790\ub294 \ubcd1\uc6d0, \uc804\ubb38 \ud074\ub9ac\ub2c9, \uc678\ub798 \uc218\uc220 \uc13c\ud130, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uacbd\uc7c1 \ud658\uacbd\uc5d0\ub294 \ub178\ubc14\ud2f0\uc2a4(Novartis AG), \ud654\uc774\uc790(Pfizer Inc.), \uc0ac\ub178\ud53c(Sanofi SA), \ubc84\ud14d\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4(Vertex Pharmaceuticals Inc.), CRISPR \ud14c\ub77c\ud4e8\ud2f1\uc2a4(CRISPR Therapeutics AG) \ub4f1 \uc8fc\uc694 \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc774 \ud3ec\ud568\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubbf8\ub798 \uc804\ub9dd \ubc0f \uae30\ud68c:<br \/>\n\uace0\uac00\uc758 \uce58\ub8cc \ube44\uc6a9 \ubb38\uc81c\ub97c \uc644\ud654\ud558\uae30 \uc704\ud574 CMS\uc758 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc811\uadfc \ubaa8\ub378(Cell and Gene Therapy Access Model)\uacfc \uac19\uc774 \uc7a5\uae30\uc801\uc778 \ud658\uc790 \uacb0\uacfc\uc5d0 \ub530\ub77c \uc9c0\ubd88\uc561\uc744 \uc5f0\ub3d9\ud558\ub294 \uac00\uce58 \uae30\ubc18 \uacc4\uc57d \ubaa8\ub378\uc774 \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc2dc\uc7a5\uc758 \uc0c8\ub85c\uc6b4 \uae30\ud68c\uc774\uc790 \ubbf8\ub798 \ubc29\ud5a5\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46031","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/46031"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=46031"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/46031\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=46031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=46031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=46031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}